首页>外文期刊>医学、药学、卫生>Kidney cancer.

Kidney cancer.

中文名称：肾癌。

ISSN：2468-4562
出版周期：Semiannual

发文量：82

期刊论文

热门论文

年度选择

更多>>

全选（0）

1.Clinical Trials Corner: Nephrectomy in the New Year

机译：临床试验角：新年肾切除术
- 作者：Parikh Mamta
- 期刊名称：《Kidney cancer.》 | 2022年第1期
- Nephrectomy;
- corners;
- Clinical Trial;
2.Extended Disease Control with Unconventional Cabozantinib Dose Increase in Metastatic Renal Cell Carcinoma

机译：扩展的疾病控制，非常规Cabozantinib剂量增加转移性肾细胞癌
- 作者：Sharma Akanksha;Elias Roy;Christie AlanaWilliams Noelle S.Pedrosa IvanBjarnason Georg A.Brugarolas James
- 期刊名称：《Kidney cancer.》 | 2022年第1期
3.Systematic Review of Treatment of Metastatic Non-Clear Cell Renal Cell Carcinoma

机译：转移性非清晰细胞肾细胞癌的系统综述
- 作者：Brown Jason R.;Calaway Adam;Castle ErikGarcia JorgeBarata Pedro C.
- 期刊名称：《Kidney cancer.》 | 2022年第1期
4.Comparative Evaluation of Safety and Efficacy of Alternate Schedule (AS) of Sunitinib in Asian and Non-Asian Patient Population for the Treatment of Metastatic Renal Cell Cancer (mRCC): A Meta-Analysis

机译：对转移性肾细胞癌（MRCC）治疗亚洲和非亚洲患者人群的替代时间表的安全性和疗效的比较评估：一项荟萃分析
- 作者：Joshi Amit;Patel Ishan;Kapse PratikshaSingh Manmohan
- 期刊名称：《Kidney cancer.》 | 2022年第1期
5.'PROBE'ing the Role of Cytoreductive Nephrectomy in Advanced Renal Cancer

机译：“探测”细胞减少肾切除术在晚期肾癌中的作用
- 作者：Bell Hannah;Cotta Brittney H.;Salami Simpa S.Kim HyungVaishampayan Ulka
- 期刊名称：《Kidney cancer.》 | 2022年第1期
6.BRCA1-Associated Protein 1 (BAP-1) as a Prognostic and Predictive Biomarker in Clear Cell Renal Cell Carcinoma: A Systematic Review

机译：BRCA1相关蛋白1（BAP-1）作为透明细胞肾细胞癌的预后和预测生物标志物：系统评价
- 作者：Gulati Shuchi;Previtera Melissa;Lara Primo N. Jr.
- 期刊名称：《Kidney cancer.》 | 2022年第1期
7.Patient-Derived Renal Cell Carcinoma Xenografts Capture Tumor Genetic Profiles and Aggressive Behaviors

机译：患者来源的肾细胞癌异种移植物捕获肿瘤遗传特征和侵略性行为
- 作者：Beserra Adriano O.;Estevan Ethiene C.;Bezerra Stephania M.Torrezan Giovana T.Ikegami AmandaDelle HumbertoCunha Isabela W.Meira Isabella T.Carraro Dirce M.Lara Primo N. Jr.Zequi Stenio C.Martins Vilma R.Santos Tiago G.
- 期刊名称：《Kidney cancer.》 | 2022年第1期
8.In Memoriam: Chris Wood

机译：在备忘录中：克里斯·伍德
- 作者：Lara Primo N. Jr.;Mulders Peter
- 期刊名称：《Kidney cancer.》 | 2022年第1期
- Lumber and lumbering;
9.Adjuvant Therapy in Renal Cell Carcinoma: Current Status and Future Directions

机译：肾细胞癌中的辅助治疗：当前状态和未来方向
- 作者：Kazarian Austin G.;Chawla Neal S.;Muddasani RamyaPal Sumanta K.
- 期刊名称：《Kidney cancer.》 | 2021年第1期
10.Cost-Effectiveness of Immunotherapy Treatments for Renal Cell Carcinoma: A Systematic Review

机译：免疫疗法治疗肾细胞癌的成本效益：系统评价
- 作者：Philip Errol J.;Zhang Sylvia;Tahir PeggyKim DanielWright FrancisBell AlexanderBorno Hala T.
- 期刊名称：《Kidney cancer.》 | 2021年第1期
- Cost Effectiveness;
- Renal Cell Carcinoma;
- immunotherapyRemote Control Center;
11.PD-L1 Expression and Treatment Implications in Metastatic Clear Cell Renal Cell Carcinoma: A Systematic Review

机译：PD-L1的表达和治疗含义在转移性透明细胞肾细胞癌中：系统评价
- 作者：Jang Albert;Sweeney Patrick L.;Barata Pedro C.Koshkin Vadim S.
- 期刊名称：《Kidney cancer.》 | 2021年第1期
- CD274 gene;
- Clear Cell Renal Cell Carcinoma;
- PDCD1 gene;
12.Real-Word Experience of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC): Results from the Canadian Kidney Cancer information system (CKCis)

机译：Cabozantinib在转移性肾细胞癌（MRCC）中的现实经验：加拿大肾脏癌信息系统（CKCIS）的结果
- 作者：Zhang Hanbo;Basappa Naveen S.;Ghosh SunitaJoy IsaiahLalani Aly-Khan A.Hansen Aaron R.Heng Daniel Y.C.Castonguay VincentKollmannsberger Christian K.Winquist EricWood LoriBjarnason Georg A.Breau Rodney H.Kapoor AnilGraham Jeffrey
- 期刊名称：《Kidney cancer.》 | 2021年第1期
- XL 184;
- Molecular Targeted Therapy;
- metastasisRenal Cell CarcinomaRHOH geneMedian;
13.Renal Function: Implications on the Surgical Treatment of RCC

机译：肾功能：对RCC手术治疗的影响
- 作者：Janetschek Günter
- 期刊名称：《Kidney cancer.》 | 2021年第1期
14.Impact of SARS-CoV-2 Pandemic on Kidney Cancer Management

机译：SARS-COV-2大流行对肾脏癌管理的影响
- 作者：Bersanelli Melissa;Porta Camillo
- 期刊名称：《Kidney cancer.》 | 2021年第2期
15.PBRM1 Mutations as a Predictive Biomarker for Immunotherapy in Metastatic Renal Cell Carcinoma: A Systematic Review

机译：PBRM1突变是转移性肾细胞癌免疫疗法的预测生物标志物：系统评价
- 作者：Castello Dias Carneiro Andre Paterno;Marques Monteiro Fernando Sabino;Soares Andrey
- 期刊名称：《Kidney cancer.》 | 2021年第2期
- PBRM1 gene;
- immunotherapy;
- Mutationmetastatic kidney cancerICI;
16.Twitter as a Tool to Spread Communication Regarding Genitourinary Cancers During the COVID-19 Pandemic

机译：Twitter作为在COVID-19大流行期间传播有关泌尿生殖器癌的交流的工具
- 作者：Salgia Sabrina;Salgia Nicholas;Prajapati SwetaSeghal IshaanBautista FrankRuel NoraSalgia MeghanSalgia Deborah A.Salgia RaviPal Sumanta K.
- 期刊名称：《Kidney cancer.》 | 2021年第2期
17.Nivolumab: 5 Years Since FDA Approval of the First Checkpoint Inhibitor for Renal Cell Carcinoma

机译：Nivolumab：自FDA批准第一个检查点肾细胞癌的第一个检查点以来
- 作者：Tsimafeyeu Ilya
- 期刊名称：《Kidney cancer.》 | 2021年第2期
18.Clinical Trials Corner: A New Look at Cytoreductive Nephrectomy

机译：临床试验角：对细胞还原性肾切除术的新看觉
- 作者：Parikh Mamta
- 期刊名称：《Kidney cancer.》 | 2021年第2期
- Clinical Trial;
- Nephrectomy;
- corners;
19.Renal Cancer Without Primary Cancer in the Kidney: Extra-Renal TFE3 Translocation Associated Renal Cell Carcinoma

机译：肾脏中没有原发性癌症的肾脏癌：肾外TFE3易位相关肾细胞癌
- 作者：Petrinec Benjamin;Vargas Bryan Morales;Harik Lara R.Master Viraj A.
- 期刊名称：《Kidney cancer.》 | 2021年第2期
20.Clinical Trials Corner: Contact After the First Round

机译：临床试验角：第一轮之后接触
- 作者：Parikh Mamta
- 期刊名称：《Kidney cancer.》 | 2021年第3期
- corners;
- Clinical Trial;
- Rounding offContact InformationCONTACT;
21.First-Line Immunotherapy Combinations in Advanced Renal Cell Carcinoma: A Rapid Review and Meta-Analysis

机译：晚期肾细胞癌的一线免疫疗法组合：快速综述和荟萃分析
- 作者：Shpilsky Jason;Catalano Paul J.;McDermott David F.
- 期刊名称：《Kidney cancer.》 | 2021年第3期
22.Active Surveillance of Small Renal Masses: A Systematic Review

机译：小肾脏的主动监视：系统评价
- 作者：Ellis Elizabeth E.;Messing Edward
- 期刊名称：《Kidney cancer.》 | 2021年第3期
23.Defining the Optimal Management Strategy for Small Renal Masses

机译：定义小肾脏的最佳管理策略
- 作者：DallEra Marc;Lara Primo N. Jr.
- 期刊名称：《Kidney cancer.》 | 2021年第3期
- Kidney;
- Optimal;
- Authority;
24.Bim Expression in Peritumoral Lymphocytes is Associated with Survival in Patients with Metastatic Clear Cell Renal Cell Carcinoma

机译：周围淋巴细胞中的BIM表达与转移性透明细胞肾细胞癌患者的生存有关
- 作者：Bhindi Bimal;Bearrick Elizabeth N.;Cheville John C.Lohse Christine M.Mason Ross J.Shah ParasHarrington SusanZhang HenanDong HaidongBoorjian Stephen A.Thompson R. HoustonLeibovich Bradley C.
- 期刊名称：《Kidney cancer.》 | 2021年第3期
25.Real-World Utilization of Oral Anticancer Agents and Related Costs in Older Adults with Metastatic Renal Cell Carcinoma in the United States

机译：美国转移性肾细胞癌老年人的口服抗癌剂和相关成本的现实利用
- 作者：Wilson Lauren E.;Spees Lisa;Pritchard JessicaGreiner Melissa A.Scales Charles D.Baggett Christopher D.Kaye DeborahGeorge Daniel J.Zhang TianWheeler Stephanie B.Dinan Michaela A.
- 期刊名称：《Kidney cancer.》 | 2021年第3期
26.Clinical Trials Corner: Reimagining RADICAL

机译：临床试验角：重新想象激进
- 作者：Parikh Mamta
- 期刊名称：《Kidney cancer.》 | 2021年第4期
27.First-Line Immuno-Oncology Combinations for Metastatic Clear Cell Renal Cell Carcinoma (mRCC): A Systematic Review of Phase III Clinical Trials

机译：转移性透明细胞肾细胞癌（MRCC）的一线免疫肿瘤组合：对III期临床试验的系统评价
- 作者：Hahn Andrew W.;Shah Amishi Y.;Campbell Matthew T.
- 期刊名称：《Kidney cancer.》 | 2021年第4期
28.Prognostic Impact of Lymphnode Metastases in Patients with Metastatic Renal Cell Carcinoma

机译：淋巴结转移对转移性肾细胞癌患者的预后影响
- 作者：Eggers Hendrik;Tiemann Marie Luise;Peters IngaKuczyk Markus AntoniusGruenwald ViktorIvanyi Philipp
- 期刊名称：《Kidney cancer.》 | 2021年第4期
29.Retrospective Study of Real-World Treatment Patterns and Outcomes in Advanced/Metastatic Renal Cell Carcinoma Patients Receiving Lenvatinib/Everolimus after Heavy Pretreatment

机译：在大量预处理后接受Lenvatinib/Everolimus的晚期/转移性肾细胞癌患者的实际治疗模式和结果的回顾性研究
- 作者：Vogelzang Nicholas J.;Monnette Alisha M.;Wang YunfeiWan YinRobert Nicholas J.Tannir Nizar M.
- 期刊名称：《Kidney cancer.》 | 2021年第4期
30.Phase Ib/II trial of Ibrutinib and Nivolumab in Patients with Advanced Refractory Renal Cell Carcinoma

机译：Ibrutinib和Nivolumab的IB/II期试验对晚期难治性肾细胞癌患者
- 作者：Parikh Mamta;Tenold Matthew E.;Qi LihongLara FrancesRobles DanielMeyers Frederick J.Lara Primo N.
- 期刊名称：《Kidney cancer.》 | 2021年第4期
31.Sarcomatoid Renal Cell Carcinoma: The Present and Future of Treatment Paradigms

机译：肉瘤类肾细胞癌：治疗范例的当前和未来
- 作者：Candelario Nellowe;Geiger Christopher;Flaig Thomas
- 期刊名称：《Kidney cancer.》 | 2021年第4期
32.Clinical Trials Corner: A Promising New Drug Class in Treating Metastatic Renal Cell Carcinoma

机译：临床试验角：治疗转移性肾细胞癌的有希望的新药类
- 作者：Parikh Mamta
- 期刊名称：《Kidney cancer.》 | 2020年第1期
- corners;
- metastatic kidney cancer;
- Clinical Trial;
33.Prognostic Value of Histologic Subtype and Treatment Modality for T1a Kidney Cancers

机译：T1A肾脏的组织学亚型和治疗方式的预后价值
- 作者：Siev Michael;Renson Audrey;Tan Hung-JuiRose Tracy L.Kang Stella K.Huang William C.Bjurlin Marc A.
- 期刊名称：《Kidney cancer.》 | 2020年第1期
34.Thickness of Perirenal Fat Predicts the Growth Pattern of Renal Cell Carcinoma

机译：周围脂肪的厚度预测肾细胞癌的生长模式
- 作者：Kashiwagi Eiji;Imada Kenjiro;Abe TatsuroKinoshita FumioMonji KeisukeShiota MasakiTakeuchi ArioInokuchi JunichiTatsugami KatsunoriEto Masatoshi
- 期刊名称：《Kidney cancer.》 | 2020年第1期
35.The Prognostic Value of DNA Methylation Markers in Renal Cell Cancer: A Systematic Review

机译：肾细胞癌中DNA甲基化标记物的预后值：系统评价
- 作者：Peters Inga;Merseburger Axel S.;Tezval HosseinLafos MarcelTabrizi Pouriya FarajMazdak MehrdadWolters MathiasKuczyk Markus A.Serth Jürgenvon Klot Christoph-A.J.
- 期刊名称：《Kidney cancer.》 | 2020年第1期
36.Clinical Outcomes by Nephrectomy Status In METEOR, A Randomized Phase 3 Trial of Cabozantinib Versus Everolimus in Patients with Advanced Renal Cell Carcinoma

机译：肾切除术在流星中的临床结局，这是晚期肾细胞癌患者的卡博替尼与依维莫司的随机3期试验
- 作者：Tannir Nizar M.;Powles Thomas;Escudier BernardDonskov FredeGrünwald ViktorSternberg Cora N.Schmidinger ManuelaSch?ffski PatrickSzczylik CezaryPeltolta KatriinaNosov DmitryMelichar BohuslavClary DouglasScheffold ChristianMotzer Robert J.Choueiri Toni K.
- 期刊名称：《Kidney cancer.》 | 2020年第1期
- XL 184;
- Certican;
- Renal Cell CarcinomaNephrectomypatient history of nephrectomyPatients;
37.A Systematic Review of Systemic Treatment Options for Advanced Non-Clear Cell Renal Cell Carcinoma

机译：对晚期非细胞肾细胞癌的系统治疗方案的系统评价
- 作者：Osterman Chelsea K.;Rose Tracy L.
- 期刊名称：《Kidney cancer.》 | 2020年第1期
38.Nephrectomy Status in the Context of Cabozantinib Treatment

机译：肾切除术在卡巴替尼治疗的背景下
- 作者：Esteghamat Naseem;Lara Primo N.;Parikh Mamta
- 期刊名称：《Kidney cancer.》 | 2020年第1期
- XL 184;
- Nephrectomy;
- Status;
39.Skeletal-Related Events in Patients with Metastatic Renal Cell Carcinoma: A Systematic Review

机译：转移性肾细胞癌患者的骨骼相关事件：系统评价
- 作者：Jang Albert;Chen Shuang R.;Xie JohnBilen Mehmet A.Barata Pedro C.
- 期刊名称：《Kidney cancer.》 | 2020年第2期
40.First-Line Immune Checkpoint Inhibitor-Based Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review

机译：基于转移性肾细胞癌的一线免疫检查点抑制剂疗法：系统评价
- 作者：Thana Myuran;Wood Lori Anne
- 期刊名称：《Kidney cancer.》 | 2020年第2期
41.Evolving Frontline Treatment Landscape for Advanced or Metastatic Renal Cell Carcinoma

机译：不断发展的前线治疗景观，用于晚期或转移性肾细胞癌
- 作者：Jain Rohit K.;Lara Primo N.
- 期刊名称：《Kidney cancer.》 | 2020年第2期
42.Biomarkers Towards New Era of Therapeutics for Metastatic Renal Cell Carcinoma

机译：朝向转移性肾细胞癌的新型治疗时代的生物标志物
- 作者：Mizuno Ryuichi;Oya Mototsugu
- 期刊名称：《Kidney cancer.》 | 2020年第2期
43.Fourth-Line Therapy in Metastatic Renal Cell Carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC)

机译：转移性肾细胞癌（MRCC）的第四线治疗：国际MRCC数据库联盟（IMDC）的结果
- 期刊名称：《Kidney cancer.》 | 2020年第2期
- Database;
- metastatic kidney cancer;
- Medicine;
44.Clinical Trials Corner: Translating Benefit to the Bone

机译：临床试验角：将益处转换为骨头
- 作者：Parikh Mamta
- 期刊名称：《Kidney cancer.》 | 2020年第2期
- bone structure;
- corners;
- Clinical Trial;
45.Renal Cell Carcinoma with Inferior Vena Cava Extension: Can Classification Be Optimized to Predict Perioperative Outcomes?

机译：肾细胞癌具有下腔静脉的延伸：可以优化分类以预测围手术期结局吗？
- 作者：Leibovich Bradley C.;Lohse Christine M.;Cheville John C.Potretzke Theodora A.Tsivian MatveyShah Paras H.Boorjian Stephen A.Thompson R. HoustonLyon Timothy D.
- 期刊名称：《Kidney cancer.》 | 2020年第2期
46.Examining the Association of Academic Rank and Productivity with Metrics of Twitter Utilization Amongst Kidney Cancer Specialists

机译：研究肾脏癌专家的学术等级和生产力与Twitter利用率指标的关联
- 作者：Salgia Nicholas J.;Feng Matthew;Prajapati DhruvHarwood RichardNissanoff MichaelDara YashRuel NoraSalgia Meghan M.Pal Sumanta K.
- 期刊名称：《Kidney cancer.》 | 2020年第2期
47.Race/Ethnicity and Survival in Metastatic Renal Cell Carcinoma: Outcomes for Patients Receiving First Line Targeted Therapies

机译：转移性肾细胞癌的种族/种族和生存：接受第一线靶向疗法的患者的结局
- 作者：Dizman Nazli;Salgia Nicholas J.;Bergerot Paulo G.Hsu JoAnnRuel NoraPal Sumanta K.
- 期刊名称：《Kidney cancer.》 | 2020年第3期
48.Comparing the Responses of Osseous Versus Soft-Tissue Metastases of Renal Cell Carcinoma to Receptor Tyrosine Kinase Inhibitors and Immunotherapy

机译：比较肾小球癌与受体酪氨酸激酶抑制剂和免疫疗法的骨与软组织转移的反应
- 作者：Tai Katherine Yuxi;El Abiad Jad M.;Morris Carol D.Markowski Mark ChristopherLevin Adam S.
- 期刊名称：《Kidney cancer.》 | 2020年第3期
49.Validation of the Correlation Between Single Nucleotide Polymorphism rs307826 in VEGFR3 and Outcome in Metastatic Clear-Cell Renal Cell Carcinoma Patients Treated with Sunitinib

机译：VEGFR3中单核苷酸多态性RS307826与转移性清透明细胞肾细胞癌患者的结果的验证
- 作者：Beuselinck Benoit;Van Brussel Thomas;Verbiest AnneliesVanmechelen MaximeCouchy GabrielleOudard StéphaneEla?di RezaRoussel EduardAlbersen MaartenDebruyne PhilipBaldewijns MarcellaMachiels Jean-PascalRichard VincentVerschaeve VincentWolter PascalRioux-Leclercq NathalieLaguerre BrigitteZucman-Rossi JessicaLambrechts Diether
- 期刊名称：《Kidney cancer.》 | 2020年第3期
50.Trends in Initial Systemic Therapy for Elderly Patients with Metastatic Clear Cell Renal Cell Carcinoma

机译：转移性透明细胞肾细胞癌的老年患者的初始全身治疗趋势
- 作者：Osterman Chelsea K.;Deal Allison M.;Milowsky Matthew I.Bjurlin Marc A.Rose Tracy L.
- 期刊名称：《Kidney cancer.》 | 2020年第3期
51.The Pan-Omics Landscape of Renal Cell Carcinoma and Its Implication on Future Clinical Practice

机译：肾细胞癌的泛词景观及其对未来临床实践的影响
- 作者：Huang Jennifer J.;Hsieh James J.
- 期刊名称：《Kidney cancer.》 | 2020年第3期
52.Clinical Trials Corner: Healthy Competition

机译：临床试验角：健康竞争
- 作者：Parikh Mamta
- 期刊名称：《Kidney cancer.》 | 2020年第4期
- corners;
- Competition;
- Clinical Trial;
53.Individualised Predictions of the Survival Benefit Due to Adjuvant Therapy in a Randomised Trial of Sorafenib after Nephrectomy for Localised Renal Cell Carcinoma

机译：肾切除术后索拉非尼的随机试验对局部肾细胞癌的随机试验，对辅助治疗引起的生存益处的个性化预测
- 作者：Lawrence Nicola J.;Martin Andrew;Davis Ian D.Troon SimonSengupta ShomikHovey ElizabethCoskinas XanthiKaplan RichardSmith BenjaminRitchie Alastair W. S.Meade AngelaGoh JeffreyGurney HowardHarrison MichelleFife KateEisen TimBlinman PrunellaStockler Martin R.
- 期刊名称：《Kidney cancer.》 | 2020年第4期
54.Clinical Trials Corner

机译：临床试验角
- 期刊名称：《Kidney cancer.》 | 2019年第1期
55.Stereotactic Body Radiation Therapy for Renal Cell Carcinoma with Inferior Vena Cava Thrombus - Initial Experience Report and Literature Review

机译：肾脏细胞癌的立体定向身体放射治疗，下腔静脉cava血栓 - 初始经验报告和文献综述
- 作者：Yuval Freifeld;Vitaly Margulis;Solomon L. WolduRobert TimmermanJames BrugarolasRaquibul Hannan
- 期刊名称：《Kidney cancer.》 | 2019年第1期
56.Cell-free Circulating Tumor DNA (ctDNA) in Metastatic Renal Cell Carcinoma (mRCC): Current Knowledge and Potential Uses

机译：转移性肾细胞癌（MRCC）中无细胞循环肿瘤DNA（CTDNA）：当前的知识和潜在用途
- 作者：Andrew W. Hahn;Roberto H. Nussenzveig;Benjamin L. MaughanNeeraj Agarwal
- 期刊名称：《Kidney cancer.》 | 2019年第1期
57.Targeted Therapy and Immunotherapy: Effect of Body Mass Index on Clinical Outcomes in Patients Diagnosed with Metastatic Renal Cell Carcinoma

机译：靶向疗法和免疫疗法：体重指数对诊断为转移性肾细胞癌的患者的临床结局的影响
- 作者：Paulo Gustavo Bergerot;Cristiane Decat Bergerot;Errol J. PhilipLuis MezaNazli DizmanJo Ann HsuSumanta Kumar Pal
- 期刊名称：《Kidney cancer.》 | 2019年第1期
58.Randomized Phase 2 Study of Trebananib (AMG 386) with or without Continued Anti-Vascular Endothelial Growth Factor Therapy in Patients with Renal Cell Carcinoma Who Have Progressed on Bevacizumab, Pazopanib, Sorafenib, or Sunitinib - Results of NCI/CTEP Protocol 9048

机译：肾细胞癌患者的Trebananib（AMG 386）的随机2阶段研究（AMG 386），有或没有持续的抗血管内皮生长因子治疗，这些患者在贝伐单抗，pazopanib，sorafenib或Sunitinib上的进展方面已进展
- 作者：Thomas J. Semrad;Susan Groshen;Chunqiao LuoSumanta PalUlka VaishampayanMonika JoshiDavid I. QuinnPhilip C. MackDavid R. GaraPrimo N. Lara
- 期刊名称：《Kidney cancer.》 | 2019年第1期
59.Real-World Outcome of 173 Metastatic Non-Clear Cell Renal Cell Carcinoma (nccRCC) Cases: The Experience of the Center Group for Genitourinary Tumors

机译：173个转移性细胞肾细胞癌（NCCRCC）病例的现实世界结果：泌尿生殖器肿瘤中心组的经验
- 作者：Almudena Martin;Javier Puente;Alvaro PintoPablo GajateTeresa Alonso GordoaEnrique GreAna HerreroConstanza MaximianoMartia GarridoIsabel GallegosM Laura VillalobosjJesus Garcia-DonasEdinson CaviedesIciar GarciaJavier EspinosaCarlos AguadoJose Angel ArranzLourdes GarciaJuan Francisco RodriguezJavier CasinelloLaura Rodriguez
- 期刊名称：《Kidney cancer.》 | 2019年第1期
60.Metastasectomy in Advanced Renal Cell Carcinoma: A Systematic Review

机译：晚期肾细胞癌的转移切除术：系统评价
- 作者：Tala Achkar;Jodi K. Maranchie;Leonard J. Appleman
- 期刊名称：《Kidney cancer.》 | 2019年第1期
- Metastasectomy;
- Renal Cell Carcinoma;
- lung metastasisPatient Reported Outcomes;
61.The 'Achilles Heel' of Metabolism in Renal Cell Carcinoma: Glutaminase Inhibition as a Rational Treatment Strategy

机译：肾细胞癌中代谢的“阿喀琉斯脚跟”：谷氨酰胺酶抑制作用作为合理治疗策略
- 作者：Christian R. Hoerner;Viola J. Chen;Alice C. Fan
- 期刊名称：《Kidney cancer.》 | 2019年第1期
62.Radiation Therapy for Renal Cell Carcinoma

机译：肾细胞癌的放射治疗
- 作者：Rachel Choi;James B. Yu
- 期刊名称：《Kidney cancer.》 | 2019年第1期
- adjuvant therapy;
- Room temperature;
- Remote Control CenterRenal Cell CarcinomaRadiotherapy;
63.What Comes After Immuno-Oncology Therapy for Kidney Cancer?

机译：肾癌免疫肿瘤治疗后发生了什么？
- 作者：Haris Zahoor;Vinay Duddalwar;Anishka DSouzaAxel S. Merseburger David I. Quinn
- 期刊名称：《Kidney cancer.》 | 2019年第2期
64.The Emerging Role of Combination Angiogenesis Inhibitors and Immune Checkpoint Inhibitors in the Treatment of Metastatic Renal Cell Cancer

机译：组合血管生成抑制剂和免疫检查点抑制剂在转移性肾细胞癌治疗中的新兴作用
- 作者：Ama Nizam;Logan P. Rhea;Brinda Gupta Jeanny B. Aragon-Ching
- 期刊名称：《Kidney cancer.》 | 2019年第2期
65.Real-World Data from a Metastatic Renal Cell Carcinoma Community-Academic Registry: Comparative Outcomes of Progression Free Survival and Overall Survival

机译：来自转移性肾细胞癌社区 - 学术注册表的现实世界数据：自由生存的比较结果和整体生存
- 作者：Sundhar Ramalingam;Mark Walker;Daniel J. George Michael R. Harrison
- 期刊名称：《Kidney cancer.》 | 2019年第2期
66.miR-22 Regulates Invasion, Gene Expression and Predicts Overall Survival in Patients with Clear Cell Renal Cell Carcinoma

机译：miR-22调节侵袭，基因表达并预测清晰细胞肾细胞癌患者的总生存率
- 作者：Xue Gong;Hongjuan Zhao;Matthias SaarDonna M. Peehl James D. Brooks
- 期刊名称：《Kidney cancer.》 | 2019年第2期
- Clear Cell Renal Cell Carcinoma;
- MicroRNAs;
- cell invasionoverall survivalPrognostic;
67.Everolimus Exposure as a Predictor of Toxicity in Renal Cell Cancer Patients in the Adjuvant Setting: Results of a Pharmacokinetic Analysis for SWOG S0931 (EVEREST), a Phase III Study (NCT01120249)

机译：Everolimus暴露是辅助环境中肾细胞癌患者毒性的预测：SWOG S0931的药代动力学分析的结果（Everest），一项III期研究（NCT01120249）
- 作者：Timothy W. Synold;Melissa Plets;Catherine M. TangenElisabeth I. HeathGanesh S. PalapattuPhilip C. MackMark N. SteinMaxwell V. MengPrimo LaraNicholas J. VogelzangIan Murchie Thompson Christopher W. Ryan
- 期刊名称：《Kidney cancer.》 | 2019年第2期
68.Sunitinib Dose Escalation in Metastatic Renal Cell Carcinoma

机译：转移性肾细胞癌中的舒尼替尼剂量升级
- 作者：Andreas Bruchbacher;Sebastian Nachbargauer;Harun Fajkovic Manuela Schmidinger
- 期刊名称：《Kidney cancer.》 | 2019年第2期
- metastatic kidney cancer;
- sunitinib;
- treatment durationpatient treatment;
69.Evolving Epidemiologic Trends of Renal Cell Cancer by Histologic Subtype: An Updated Analysis of the California Cancer Registry

机译：通过组织学亚型的肾细胞癌的流行病学趋势不断发展：加利福尼亚癌症登记处的最新分析
- 作者：Mamta Parikh;Jasmine C. Huynh;Ann BrunsonTheresa Keegan Primo N. Lara
- 期刊名称：《Kidney cancer.》 | 2019年第3期
70.Current Trends in Partial Nephrectomy After Guideline Release: Health Disparity for Small Renal Mass

机译：指南发布后部分肾切除术的当前趋势：小肾脏质量的健康差异
- 作者：Allison M. May;Aniradh Gudura;Joshua FerneliusSyed J. RazaFacundo DavaroSameer A. Siddiqui Zachary A. Hamilton
- 期刊名称：《Kidney cancer.》 | 2019年第3期
71.Collecting Duct Carcinoma of the Kidney: Analysis of Our Experience at the SPANISH 'Grupo Centro' of Genitourinary Tumors

机译：收集肾脏的管道癌：分析我们在西班牙泌尿植物肿瘤的“ Grupo Centro”的经验
- 作者：A. Pinto;M. Garrido;C. AguadoT. AlonsoP. GajateC. MaximianoI. Garcia-CarboneroA. Martin1. GallegosJ.A. ArranzJ. Puente E. Gre
- 期刊名称：《Kidney cancer.》 | 2019年第3期
72.Targeted Therapies Following First-Line Immune Checkpoint Inhibitor Combination in Metastatic Renal Cell Carcinoma: A Single Center Experience

机译：转移性肾细胞癌的一线免疫检查点抑制剂组合后的靶向疗法：单个中心体验
- 作者：Nazli Dizman;Paulo G. Bergerot;Cristiane D. BergerotJoAnn Hsu Sumanta K. Pal
- 期刊名称：《Kidney cancer.》 | 2019年第3期
73.Double Immune Checkpoint Blockade in Renal Cell Carcinoma

机译：肾细胞癌的双免疫检查点阻滞
- 作者：M. Luyo;L. Carril-Ajuria;F. SchutzD. Castellano G. De Velasco
- 期刊名称：《Kidney cancer.》 | 2019年第3期
74.A Review of Papillary Renal Cell Carcinoma and MET Inhibitors

机译：乳头状肾细胞癌和MED抑制剂的综述
- 作者：Katherine Emilie Rhoades Smith Mehmet Asim Bilen
- 期刊名称：《Kidney cancer.》 | 2019年第3期
75.Genomic Instability in Kidney Cancer: Etiologies and Treatment Opportunities

机译：肾癌的基因组不稳定：病因和治疗机会
- 作者：Patrick G. Pilie
- 期刊名称：《Kidney cancer.》 | 2019年第3期
76.Clinical Trials Corner

机译：临床试验角
- 作者：Parikh;Mamta
- 期刊名称：《Kidney cancer.》 | 2019年第4期
77.Predictors of Survival Outcomes in Non-Metastatic Renal Cell Carcinoma in Latin America and Spain: A Multicentric Analysis

机译：在拉丁美洲和西班牙非转移性肾细胞癌中生存结果的预测指标：多中心分析
- 作者：Stenio de Cassio Zequi;Thiago Camelo Mourao;Max Moura de OliveiraMaria Paula CuradoGuilhermo GueglioWalter Henriques da CostaAlvaro ZunigaRuben BengioCarlos ScorticatiFrancisco Rodriguez
- 期刊名称：《Kidney cancer.》 | 2019年第4期
78.Utility of FDG-PET/CT in Patients with Advanced Renal Cell Carcinoma with Osseous Metastases: Comparison with CT and ~99mTc-MDP Bone Scan in a Prospective Clinical Trial

机译：FDG-PET/CT在患有骨转移的晚期肾细胞癌患者中的效用：与前瞻性临床试验中的CT和〜99MTC-MDP骨扫描相比
- 作者：Elizabeth H. Dibble;Sasha Kravets;SuChun ChengChristopher SakellisKathryn P. GrayAma AbbottDominick BosseMark M. Pomerantz
- 期刊名称：《Kidney cancer.》 | 2019年第4期
79.Real-World Results from One Year of Therapy with Tivozanib

机译：现实世界中的一年治疗tivozanib
- 作者：Michael Staehler;Annabel K. Spek;Severin RodlerMelanie SchottJozefina CasuscelliLena MittelmeierMarcus Schlemmer
- 期刊名称：《Kidney cancer.》 | 2019年第4期
80.The Value of Multiparametric MRI for Assessment of Inferior Vena Cava Wall Invasion by Renal Cell Carcinoma Thrombus: A Prospective Feasibility Study

机译：多参数MRI的价值用于评估肾细胞癌血栓的下腔静脉壁入侵：一项前瞻性可行性研究
- 作者：Tim J. van Oostenbrugge;Johan F. Langenhuijsen;Jurgen J. FuttererPeter F.A. Mulders
- 期刊名称：《Kidney cancer.》 | 2019年第4期
81.Individualization of Dose and Schedule Based On Toxicity for Oral VEGF Drugs in Kidney Cancer

机译：基于对肾癌口服VEGF药物的毒性的剂量和时间表的个性化
- 作者：Ambika Parmar;Georg A. Bjarnason
- 期刊名称：《Kidney cancer.》 | 2019年第4期
82.Immune Checkpoint Inhibition, the Key to Success in Renal Cell Carcinoma?

机译：免疫检查点抑制，这是肾细胞癌成功的关键？
- 作者：E.A. Reijm;J.V. van Thienen;S. WilgenhofA. BexJ.B.A.G. Haanen
- 期刊名称：《Kidney cancer.》 | 2019年第4期
83.What We Have Learnt from CARMENA and SURTIME and What Should Be Done Differently in Future Trials on Cytoreductive Nephrectomy

机译：我们从CARMENA和SURTIME中学到了什么，以及在未来的细胞减灭性肾切除术试验中应该采取哪些不同的措施
- 作者：Zondervan Patricia J.;Bex Axel
- 期刊名称：《Kidney cancer.》 | 2022年第2期
84.Hereditary Renal Cell Carcinoma

机译：Hereditary Renal Cell Carcinoma
- 作者：Dawsey Scott J.;Gupta Shilpa
- 期刊名称：《Kidney cancer.》 | 2022年第2期
85.The Current Status of Kidney Cancer Urine Markers - A Systematic Review

机译：肾癌尿液标志物的现状 - 系统评价
- 作者：Koeditz Barbara;Heidenreich Axel;von Brandenstein Melanie
- 期刊名称：《Kidney cancer.》 | 2022年第2期
- Renal cell carcinoma;
- detection;
- progression;
- differentiation;
- markers;
- urine;
- RENAL-CELL CARCINOMA;
- INJURY MOLECULE-1;
- BIOMARKER;
- BIOPSY;
86.Geographical Differences in Kidney Cancer Outcomes of Patients Treated with Immunotherapy: A Systematic Review

机译：接受免疫治疗的患者肾癌结局的地理差异：系统评价
- 作者：Goncalves Vinicius Knackfuss;Marques Monteiro Fernando Sabino;Gazola Antonia AngeliPizzolo FelipeHubner Julia ElisaPellegrini RodrigoBorba AlessandraFay Andre P.
- 期刊名称：《Kidney cancer.》 | 2022年第2期
87.A Systematic Review of Immune Checkpoint Inhibitors in Non-Clear-Cell Renal Cancer

机译：免疫检查点抑制剂在非透明细胞肾癌中的系统评价
- 作者：Palma dos Reis Ana Filipa;Simao Diana;Odeny ThomasRodrigues ChiaraFontes-Sousa Marioda Luz RicardoChowdry Rajasree PiaWelsh Sarah J.Paller ChanningBarata Pedro C.
- 期刊名称：《Kidney cancer.》 | 2022年第2期
88.Evaluating the Optimal Duration of Immunotherapy in Kidney Cancer

机译：评估肾癌免疫治疗的最佳持续时间
- 作者：Parikh Mamta;Lara Primo N.
- 期刊名称：《Kidney cancer.》 | 2022年第2期
89.EAU 2022 Highlights on Renal Cell Carcinoma

机译：EAU 2022 Highlights on Renal Cell Carcinoma
- 作者：van Oostenbrugge Tim J.;Mulders Peter F. A.
- 期刊名称：《Kidney cancer.》 | 2022年第3期
90.SETD2 Regulates the Methylation of Translation Elongation Factor eEF1A1 in Clear Cell Renal Cell Carcinoma

机译：SETD2 调控透明细胞肾细胞癌中翻译延伸因子 eEF1A1 的甲基化
- 作者：Hapke Robert;Venton Lindsay;Rose Kristie LindsaySheng QuanhuReddy AnupamaPrather RebeccaJones AngelaRathmell W. KimrynHaake Scott M.
- 期刊名称：《Kidney cancer.》 | 2022年第3期
- SETD2;
- clear cell renal cell carcinoma;
- protein translation;
- eEF1A1;
- proteomics;
- ENRICHMENT ANALYSIS;
- LYSINE METHYLTRANSFERASE;
- AMINO-ACIDS;
- FACTOR 1A;
- EXPRESSION;
- IDENTIFICATION;
- REPLICATION;
- CHROMATIN;
- PROTEINS;
- METTL21B;
91.Logical Imputation to Optimize Prognostic Risk Classification in Metastatic Renal Cell Cancer

机译：优化转移性肾细胞癌预后风险分类的逻辑插补
- 作者：Maurits Jake S. F.;van der Zanden Loes F. M.;Diekstra Meta H. M.Ambert ValentinCastellano DanielGarcia-Donas JesusGuarch Troyas RosaGuchelaar Henk-JanJaehde UlrichJunker KerstinMartinez-Cardus AnnaRadu Marius T.Rodriguez-Antona CristinaRoessler MaxWarren AnneEiseng TimOosterwijk EgbertKiemeneya Lambertus A. L. M.Vermeulen Sita H.
- 期刊名称：《Kidney cancer.》 | 2022年第3期
92.Chimeric Antigen Receptor (CAR) T-cell Treatment in Renal Cell Carcinoma: Current Clinical Trials and Future Directions

机译：嵌合抗原受体（CAR）T细胞治疗肾细胞癌：当前临床试验和未来方向
- 作者：Lyou Yung;Dorff Tanya B.
- 期刊名称：《Kidney cancer.》 | 2022年第3期
- Renal cell carcinoma;
- CAR T-cells;
- cytokine release syndrome;
- chimeric antigen receptor;
- THERAPY;
- MANAGEMENT;
- SUNITINIB;
- CD70;
- IMMUNOTHERAPY;
- INTERFERON;
- FREQUENCY;
- NIVOLUMAB;
- BIOMARKER;
- TARGET;
93.In Memoriam: Nicholas J. Vogelzang MD Obituary

机译：In Memoriam: Nicholas J. Vogelzang MD Obituary
- 作者：Lara Primo N. Jr.
- 期刊名称：《Kidney cancer.》 | 2022年第3期
94.Clinical Trials Corner: Another Approach to Treatment of Advanced Papillary Renal Cell Carcinoma

机译：临床试验角：治疗晚期状肾细胞癌的另一种方法
- 作者：Parikh Mamta
- 期刊名称：《Kidney cancer.》 | 2022年第4期
95.Activity of Immunotherapy Regimens on Primary Renal Tumours: A Systematic Review

机译：免疫治疗方案对原发性肾肿瘤的活性：系统评价
- 作者：Jones James O.;Ince William H. J.;Welsh Sarah J.Stewart Grant D.
- 期刊名称：《Kidney cancer.》 | 2022年第4期
96.Systematic Review of Comparative Studies of 3D Models for Preoperative Planning in Minimally Invasive Partial Nephrectomy

机译：微创肾部分切除术术前规划三维模型比较研究的系统评价
- 作者：Piramide Federico;Duarte Jr Dorival;Amparore DanielePiana AlbertoDe Cillis SabrinaVolpi GabrieleMeziere JulietteFiori CristianPorpiglia FrancescoCheccucci Enrico
- 期刊名称：《Kidney cancer.》 | 2022年第4期
- 3D models;
- partial nephrectomy;
- mini-invasive surgery;
- RCC;
- preoperative planning;
- ROBOTIC PARTIAL NEPHRECTOMY;
- RENAL MALIGNANCIES;
- PHYSICAL MODELS;
- HYPOTHERMIA;
- UROLOGISTS;
- SURGERY;
- QUALITY;
- REALITY;
97.Immune Checkpoint Inhibitors in the Pre-operative Setting and Impact on the Primary Renal Tumor

机译：术前免疫检查点抑制剂及其对原发性肾肿瘤的影响
- 作者：Gulati Shuchi;Lara Primo Nery
- 期刊名称：《Kidney cancer.》 | 2022年第4期

客服邮箱：kefu@zhangqiaokeyan.com

客服微信
服务号